Abstract:
Portal vein embolization is a treatment option to achieve a sufficient future remnant liver volume for patients with central liver tumours requiring an extended resection with an extensive parenchymal loss. However, molecular mechanisms of this intervention are up to now poorly understood. The objective of this prospective pilot study was the characterization of molecular events leading to late hypertrophy of the non-embolized liver tissue in the human liver.
Projects: C3: Zonation of metabolism and its regulation
Dig Liver Dis
Dig Liver Dis 44(8): 681-8
5th May 2012
Falk Rauchfuss, Sandro Lambeck, Ralf A Claus, Janina Ullmann, Thomas Schulz, Martina Weber, Katrin Katenkamp, Reinhard Guthke, Michael Bauer, Utz Settmacher
Authors
Attributions
None
Scales
Not Specified
- Created: 30th Nov 2012 at 14:45
- Last updated: 24th Oct 2013 at 16:16
Related items
